|
|
Association of pulmonary alveolar proteinosis and fibrosis: Patient with GATA2 deficiency
A. Ballerie
,
S. Nimubona
,
C. Meunier
,
F.L. Gutierrez
,
B. Desrues
et al.
Journal articles
hal-01406071v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies
C. Boglione-Kerrien
,
S. Picard
,
C. Tron
,
S. Nimubona
,
Jean-Pierre Gangneux
et al.
Journal articles
hal-01685802v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Skin manifestations among GATA2-deficient patients
A. Polat
,
M. Dinulescu
,
S. Fraitag
,
S. Nimubona
,
F. Toutain
et al.
Journal articles
hal-01780493v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Population Pharmacokinetics of Posaconazole Tablets and Monte Carlo Simulations To Determine whether All Patients Should Receive the Same Dose
Antoine Petitcollin
,
C. Boglione-Kerrien
,
C. Tron
,
S. Nimubona
,
S. Lalanne
et al.
Journal articles
hal-01631527v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey.
A. Cornillet
,
Christophe Camus
,
S. Nimubona
,
Virginie Gandemer
,
Pierre Tattevin
et al.
Journal articles
hal-00699980v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Comparison of Clinical and Biological Features of Invasive Aspergillosis in Neutropenic and Non-Neutropenic Patients
A. Cornillet
,
Christophe Camus
,
S. Nimubona
,
Virginie Gandemer
,
Pierre Tattevin
et al.
16th Congress of the International Society for Human and Animal Mycology, 2006, Paris, France
Conference papers
hal-00700372v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|